Nyxoah SA Ordinary Shares
Market Cap
140M
Short interest (Jul 15)
0.4%
Net Short (Jul 27 ): 0.0%
Borrow Fee
15.76%
↓ 11.9%
Available Shares
400K
↓ 42.1%
Price Chart
Company Overview
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.
Company Info
Market Data
Short Interest
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.